With its roots in health insurance and the late 2018 merger with top-tier pharmacy benefit manager Express Scripts (now called Evernorth), Cigna provides healthcare-related services through ...

Eli Lilly delivered above-consensus results in the second quarter, surpassing Wall Street’s revenue and non-GAAP profit ...

Discover Marpai, Inc.'s Q2 2025 earnings insights, highlighting the transformative relaunch of MarpaiRx, cost reductions, and a roadmap to profitability ...

Over the past two years, our area has experienced "mass closures" of several pharmacy chains and independent stores, ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.33, with a high estimate of $82.00 and a low estimate of $67.00. Marking an increase of 2 ...

Federal law bans state meddling in self-insured benefits. States want to curb pharmacy benefit managers. Regulators are ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Managing the cost of GLP-1 drugs for weight loss is the top priority in pharmacy benefits, says Mercer survey.

An equitable approach to prescription medication use — or pharmacoequity — can help minimize the risk of these complications, ...

With strategic initiatives like these, Elevance seeks to grow at a fast pace in the long run. Specifically, management is targeting at least 12% adjusted earnings per share growth compounded annually ...

The Oncology Institute, Inc. (NASDAQ: TOI) Q2 2025 Earnings Call Transcript August 13, 2025 The Oncology Institute, Inc.

Wellgistics Health (WGRX) announced the termination of its equity purchase agreement with Hudson Global Ventures. The ELOC was an effective tool ...